ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Laboratory Operations at Beam Therapeutics - ApplyBlast

Associate Laboratory Operations

Beam Therapeutics

11 days ago

4.1 on Glassdoor

Cambridge, Massachusetts, United States

Onsite

Full Time

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Beam Therapeutics is seeking an Associate-level operations professional to support laboratory operations and facility management for both R&D and GMP environments. The role involves hands-on experience in regulated cGMP manufacturing or GMP laboratory settings, ensuring compliance with cGMP, Good Documentation Practices, and ALCOA+ data integrity principles. The Associate will manage the site Computerized Maintenance Management System (CMMS), oversee asset records, and support equipment qualification and maintenance activities.

Responsibilities

Execute cGMP-compliant lab operations and facility support activities
Manage CMMS functions including asset records and work order lifecycle
Support equipment qualification, calibration, and maintenance processes

Skills

Qualifications

BS in a life science or other relevant scientific discipline

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.